Acromegaly
Showing 1 - 25 of 236
Therapies in Acromegaly Disease: Acral Morpho-functional Study
Recruiting
- Acromegaly
- Medical surgery therapy
-
Milano, ItalyIstituto Auxologico Italiano IRCCS San Luca
Jul 25, 2023
Acromegaly: Balance, Falls and Fracture Risk
Not yet recruiting
- Acromegaly
- HR-pQCT
- +7 more
-
Aalborg, North Denmark Region, DenmarkAalborg University Hospital
Mar 3, 2023
A Prospective Study of Outcome After Therapy for Acromegaly
Active, not recruiting
- Acromegaly
- Surgery for acromegaly
- +3 more
-
New York, New YorkNeuroendocrine Unit; Columbia University Medical Center, 180 For
Oct 24, 2022
Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)
Terminated
- Acromegaly
- Pegvisomant
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 12, 2022
Acromegaly Trial (Diet)
Not yet recruiting
- Acromegaly
- Diet
- (no location specified)
Jul 18, 2022
Satisfaction With Somatostatin Analogue Injections in Acromegaly
Not yet recruiting
- Acromegaly
- (no location specified)
Aug 9, 2022
Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)
Recruiting
- Acromegaly Due to Pituitary Adenoma
- GIP-A
- Placebo
-
Copenhagen, DenmarkDepartment of Biomedical Sciences
Nov 1, 2022
PegvisOMant and the Immune SystEm (PROMISE)
Active, not recruiting
- Acromegaly
-
Rome, ItalyDepartment of Experimental Medicine, "Sapienza" University of Ro
Nov 6, 2022
Acromegaly: A Pattern of Treatment and Comparative Effectiveness
Recruiting
- Acromegaly
- Transnasal butterfly surgery
- +2 more
-
Guangzhou, Guangdong, ChinaChina Acromegaly Organization
Mar 14, 2022
Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)
Completed
- Pituitary ACTH Hypersecretion
- +3 more
- Cholecalciferol 15000 UNT/ML Oral Solution
-
Moscow, Russian FederationEndocrinology Research Centre, Moscow
Aug 10, 2022
(RWS) of Lanreotide Autogel for Treatment of Acromegaly in China
Recruiting
- Acromegaly
-
Beijing, China
- +11 more
Jul 13, 2022
Acromegaly Trial in Beijing (SYHX2008 injection, Octreotide Acetate Microspheres for Injection injection, Sandostatin ®
Recruiting
- Acromegaly
- SYHX2008 injection
- +3 more
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Mar 13, 2023
Acromegaly Trial in Novara (Usual clinical practice + hypoproteic diet)
Not yet recruiting
- Acromegaly
- Usual clinical practice + hypoproteic diet
-
Novara, Italy: Italy Pediatric Endocrine Service of AOU Maggiore della Carità
Mar 26, 2022
Pituitary Tumors and Related Hypothalmic Disorders
Recruiting
- Panhypopituitarism
- +3 more
- MRI
- Tissue specimen collection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Genetics of Endocrine Tumours - Familial Isolated Pituitary
Recruiting
- Acromegaly
- +5 more
-
London, United Kingdom
- +1 more
Oct 17, 2022
Peri-operative Dynamics of the Growth Hormone Axis in Acromegaly
Recruiting
- Acromegaly
- Oral glucose tolerance test
-
Los Angeles, CaliforniaCedars-Sinai Medical Center, Pituitary Center
Sep 13, 2021
Bone MicroArchitecture in Acromegaly
Completed
- Acromegaly
- Osteoporosis Risk
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University
Jul 12, 2021
Sleep Apnea in Acromegaly After Surgery
Recruiting
- Sleep Apnea
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 18, 2021
Treatment Patterns and Treatment Outcomes for Acromegaly
Recruiting
- Acromegaly
-
New York, New YorkNeuroendocrine Unit at Columbia University Irving Medical Center
Jul 12, 2021
Relapsing GH Pituitary Adenomas After Surgery
Recruiting
- Acromegaly
-
Strasbourg, FranceService Médecine Interne, Endocrinologie et Nutrition - Hôpitaux
Nov 24, 2021
Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)
Recruiting
- Acromegaly
- GEP-NET
- Debio 4126
- +2 more
-
Copenaghen, Denmark
- +34 more
Jan 27, 2023